Bladder cancer: Pembrolizumab is superior to chemotherapy
- PMID: 28266514
- DOI: 10.1038/nrurol.2017.38
Bladder cancer: Pembrolizumab is superior to chemotherapy
Comment on
-
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.N Engl J Med. 2017 Mar 16;376(11):1015-1026. doi: 10.1056/NEJMoa1613683. Epub 2017 Feb 17. N Engl J Med. 2017. PMID: 28212060 Free PMC article. Clinical Trial.
References
-
- N Engl J Med. 2017 Mar 16;376(11):1015-1026 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical